Hello, everyone, and nice to see you again after an extended respite that, in part, involved observing ancient traditions. We are back now, though, and revving up the proverbial engines. Of course, this requires a few cups of stimulation — our choice today is coconut for those who like to track this sort of thing. As always, you are invited to join us. Remember, no prescription is required. So no rebates must be calculated. A nice thing, yes? Meanwhile, here are some tidbits to get you going. Hope all goes well today and do keep in touch. …

President Trump is set to nominate Dr. Stephen Hahn to lead the Food and Drug Administration, pending completion of the vetting process, according to STAT. Hahn, an oncologist, is the chief medical executive at MD Anderson Cancer Center in Houston. Trump interviewed him for the job a month ago. A third person familiar with White House thinking confirmed that Hahn remained the frontrunner and that the administration was completing paperwork and final background checks.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • One may observe that one hopes that the good Dr Hahn will actually be properly vetted. Then again “past returns are no guarantee of future results” – we may be pleasantly surprised?

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy